| Revenue growth | FY26: -8% YoY; Q4 FY26: -31% YoY. |
|---|---|
| Margins | FY26 EBITDA margin 31% vs 37% YoY. |
| Order book | Received trial orders in Advanced Contrast Media from Japan. |
| Demand visibility | PI segment de-stocking complete; robust orders expected. |
| Management confidence | Strong visibility on underlying demand; expecting normalization. |
Growth
FY26 revenue fell 8% YoY; PAT dropped 19% to ₹2,478 mn. Q4 FY26 showed QoQ recovery with revenue up 22%.
Outlook
Ground-breaking for Vizag project; R&D center completion by Sept 2026. Expect normalization and robust PI segment orders.
Risks
Declining revenues in PI & API segment (-35.6% YoY) and increased operating costs impacting EBITDA margins.
Earnings Call filed with BSE, NSE: BLUEJET. Summary written with AI assistance from the document.
Blue Jet Healthcare Ltd: key numbers
- Share price
- ₹545.50
- Market cap
- ₹9,463 Cr
- Revenue (annual)
- ₹947.3 Cr
- Net profit (annual)
- ₹247.8 Cr
- P/E (TTM)
- 40.3×Sector 47.4×
- Promoter holding
- 73.15%-6.66% QoQ
- FII holding
- 0.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Jet Healthcare Ltd
All →Blue Jet Healthcare Annual General Meeting
Blue Jet Healthcare held its 58th AGM, approving audited financials, a Re 1.20 dividend, and director re-appointments. No material amendments were noted.
Blue Jet Healthcare Annual Report
Blue Jet Healthcare Limited has released its Annual Report for FY 2025-26. The 58th Annual General Meeting is scheduled for September 21, 2026, via video conferencing.
Blue Jet Healthcare Business Update
Blue Jet Healthcare Limited has released its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. The report details the company's ESG performance and statutory disclosures.
Blue Jet Healthcare Annual General Meeting
Blue Jet Healthcare Limited will hold its 58th Annual General Meeting on September 21, 2026. The agenda includes a final dividend recommendation of ₹1.20 per share.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of INR 293 crores (+25% QoQ) and EBITDA of INR 98 crores. Management highlighted a shift toward higher-value PI and API verticals alongside significant upcoming capex.
Blue Jet Healthcare Earnings Call Transcript: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of ₹2,931mn, up 25% QoQ but down 17% YoY. Management is focusing on capacity expansion and forward integration into advanced contrast media intermediates.